Updated

Updated · PR Newswire · Jun 12

In Vitro Toxicology Testing Market to Hit $20.97 Billion by 2031 as Non-Animal Methods Gain

Updated

Updated · PR Newswire · Jun 12

In Vitro Toxicology Testing Market to Hit $20.97 Billion by 2031 as Non-Animal Methods Gain

1 articles · Updated · PR Newswire · Jun 12

$20.97 billion is the projected size of the in vitro toxicology testing market in 2031, up from $12.69 billion in 2026, implying a 10.6% annual growth rate, according to MarketsandMarkets.
Demand is being driven by a shift toward non-animal testing, tighter product-safety regulation, and broader use of predictive toxicity screening in pharmaceuticals, chemicals, cosmetics, food, and medical devices.
Products led the market in 2025, with reagents and consumables holding a 27.8% share as repeated use in studies and rising pharma R&D sustained spending.
North America held the largest regional share at 39.3% in 2025, while organ toxicity testing was flagged as the fastest-growing segment over the forecast period.

Sources

Center100%

Beyond 3D cell models, what emerging technology will be the next disruptor in the $21 billion toxicology testing market?

Can new AI-powered safety tests offset the global drug development disruptions caused by the recent U.S. BIOSECURE Act?

As labs adopt non-animal methods, what critical safety questions can still only be answered by traditional in vivo toxicology testing?

1 total

Center100%